First published 9/28/2026, 3:48:15 PM · Last updated 9/28/2026, 3:48:15 PM

Routine CYP2C19 Genotyping, Antiplatelet Prescription Changes, and Clinical Outcomes After PCI in Chinese Patients With Coronary Heart Disease: A Single‐Center Retrospective Study

A Wiley journal article (published 2026-01-01) reports a single-center retrospective study examining CYP2C19 genotyping, changes in antiplatelet prescriptions, and clinical outcomes after percutaneous coronary intervention in patients described as Chinese. The excerpt supplied contains no additional methodological details or results.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 2/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article presents clinical research on genotype-guided antiplatelet prescribing after PCI among Chinese patients.

Location

Sources

Routine CYP2C19 Genotyping, Antiplatelet Prescription Changes, and Clinical Outcomes After PCI in Chinese Patients With Coronary Heart Disease: A Single‐Center Retrospective Study

Report an issue